European Pharmaceutical Review

DECEMBER 4, 2023

Excipients market opportunities and limitations Major contributing factors regarding growth of the pharmaceutical excipients market are: increasing demand for generic drugs and drug products, increased investment in R&D for the development of novel excipients and rising emphasis on patient-centric formulations.

Pharmaceutical Companies 92

Pharmaceutical Companies Pharmaceutical Companies 92

European Pharmaceutical Review

AUGUST 19, 2022

Rising demand for therapeutics, especially in developing markets, is expected to expand the global pharmaceutical contract manufacturing market to $130.2 Based on region, China, the world`s second largest economy, is forecast to reach a projected market size of $21.1 billion by 2026. Within the $130.2 percent CAGR. percent, 4.1

Packaging 91

Packaging Compounding 91

European Pharmaceutical Review

JULY 21, 2023

Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. What are the top three supply-related challenges facing pharmaceutical manufacturers?

Vaccines 96

Vaccines FDA Communication Hospitals 96

pharmaphorum

APRIL 15, 2021

The pharma organisation prides itself on having an open, collaborative, “science first” approach to help ensure breakthrough discoveries have the very best chance of long-term success in bringing new treatment options to patients worldwide. When it comes to developing cutting-edge innovations, Astellas aims to be at the forefront.

Labelling 63

Labelling Communication FDA Pharmaceutical Companies 63

Pharmaceutical Technology

JANUARY 25, 2023

But that is changing; technological and cultural shifts mean decentralised research – where part or all of a clinical trial is conducted remotely – is on the rise. Virtual trials increased 50% year on year between 2020 and 2021 and evidence suggests the frontiers of the global clinical trial map are expanding.

Vaccines 59

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 59

Pharmaceutical Technology

JANUARY 25, 2023

But that is changing; technological and cultural shifts mean decentralised research – where part or all of a clinical trial is conducted remotely – is on the rise. Virtual trials increased 50% year on year between 2020 and 2021 and evidence suggests the frontiers of the global clinical trial map are expanding.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 52